The global Central Nervous System (CNS) Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Central Nervous System (CNS) Drug market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Central Nervous System (CNS) Drug market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Central Nervous System (CNS) Drug market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson?s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer?s) or voluntary motion (in movement disorders).
This report aims to provide a comprehensive presentation of the global market for Central Nervous System (CNS) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System (CNS) Drug. This report contains market size and forecasts of Central Nervous System (CNS) Drug in global, including the following market information:
- Global Central Nervous System (CNS) Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prescription Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Central Nervous System (CNS) Drug include Johnson & Johnson, Pfizer Inc, Novartis AG, GSK, Eli Lilly, Teva, Otsuka Pharmaceutical Co., Ltd, Biogen Inc and Boehringer Ingelheim, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Central Nervous System (CNS) Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Central Nervous System (CNS) Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Central Nervous System (CNS) Drug Market Segment Percentages, by Type, 2022 (%)
Global Central Nervous System (CNS) Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Central Nervous System (CNS) Drug Market Segment Percentages, by Application, 2022 (%)
- MS Therapeutics
- Antipsychotic Drugs
- Depression Drugs
- Epilepsy Drugs
- Others
Global Central Nervous System (CNS) Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Central Nervous System (CNS) Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Central Nervous System (CNS) Drug revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Central Nervous System (CNS) Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Pfizer Inc
- Novartis AG
- GSK
- Eli Lilly
- Teva
- Otsuka Pharmaceutical Co., Ltd
- Biogen Inc
- Boehringer Ingelheim
- Roche
- UCB
- Tekeda
- Shanghai Fosun
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Central Nervous System (CNS) Drug, market overview.
Chapter 2: Global Central Nervous System (CNS) Drug market size in revenue.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Central Nervous System (CNS) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Central Nervous System (CNS) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Central Nervous System (CNS) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Central Nervous System (CNS) Drug Overall Market Size
2.1 Global Central Nervous System (CNS) Drug Market Size: 2022 VS 2030
2.2 Global Central Nervous System (CNS) Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Central Nervous System (CNS) Drug Players in Global Market
3.2 Top Global Central Nervous System (CNS) Drug Companies Ranked by Revenue
3.3 Global Central Nervous System (CNS) Drug Revenue by Companies
3.4 Top 3 and Top 5 Central Nervous System (CNS) Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Central Nervous System (CNS) Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Central Nervous System (CNS) Drug Players in Global Market
3.6.1 List of Global Tier 1 Central Nervous System (CNS) Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Central Nervous System (CNS) Drug Market Size Markets, 2022 & 2030
4.1.2 Prescription Drugs
4.1.3 OTC
4.2 By Type - Global Central Nervous System (CNS) Drug Revenue & Forecasts
4.2.1 By Type - Global Central Nervous System (CNS) Drug Revenue, 2018-2023
4.2.2 By Type - Global Central Nervous System (CNS) Drug Revenue, 2024-2030
4.2.3 By Type - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Central Nervous System (CNS) Drug Market Size, 2022 & 2030
5.1.2 MS Therapeutics
5.1.3 Antipsychotic Drugs
5.1.4 Depression Drugs
5.1.5 Epilepsy Drugs
5.1.6 Others
5.2 By Application - Global Central Nervous System (CNS) Drug Revenue & Forecasts
5.2.1 By Application - Global Central Nervous System (CNS) Drug Revenue, 2018-2023
5.2.2 By Application - Global Central Nervous System (CNS) Drug Revenue, 2024-2030
5.2.3 By Application - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Central Nervous System (CNS) Drug Market Size, 2022 & 2030
6.2 By Region - Global Central Nervous System (CNS) Drug Revenue & Forecasts
6.2.1 By Region - Global Central Nervous System (CNS) Drug Revenue, 2018-2023
6.2.2 By Region - Global Central Nervous System (CNS) Drug Revenue, 2024-2030
6.2.3 By Region - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Central Nervous System (CNS) Drug Revenue, 2018-2030
6.3.2 US Central Nervous System (CNS) Drug Market Size, 2018-2030
6.3.3 Canada Central Nervous System (CNS) Drug Market Size, 2018-2030
6.3.4 Mexico Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Central Nervous System (CNS) Drug Revenue, 2018-2030
6.4.2 Germany Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4.3 France Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4.4 U.K. Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4.5 Italy Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4.6 Russia Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4.7 Nordic Countries Central Nervous System (CNS) Drug Market Size, 2018-2030
6.4.8 Benelux Central Nervous System (CNS) Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Central Nervous System (CNS) Drug Revenue, 2018-2030
6.5.2 China Central Nervous System (CNS) Drug Market Size, 2018-2030
6.5.3 Japan Central Nervous System (CNS) Drug Market Size, 2018-2030
6.5.4 South Korea Central Nervous System (CNS) Drug Market Size, 2018-2030
6.5.5 Southeast Asia Central Nervous System (CNS) Drug Market Size, 2018-2030
6.5.6 India Central Nervous System (CNS) Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Central Nervous System (CNS) Drug Revenue, 2018-2030
6.6.2 Brazil Central Nervous System (CNS) Drug Market Size, 2018-2030
6.6.3 Argentina Central Nervous System (CNS) Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Central Nervous System (CNS) Drug Revenue, 2018-2030
6.7.2 Turkey Central Nervous System (CNS) Drug Market Size, 2018-2030
6.7.3 Israel Central Nervous System (CNS) Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Central Nervous System (CNS) Drug Market Size, 2018-2030
6.7.5 UAE Central Nervous System (CNS) Drug Market Size, 2018-2030
7 Central Nervous System (CNS) Drug Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Major Product Offerings
7.1.4 Johnson & Johnson Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Pfizer Inc
7.2.1 Pfizer Inc Company Summary
7.2.2 Pfizer Inc Business Overview
7.2.3 Pfizer Inc Central Nervous System (CNS) Drug Major Product Offerings
7.2.4 Pfizer Inc Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Central Nervous System (CNS) Drug Major Product Offerings
7.3.4 Novartis AG Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Central Nervous System (CNS) Drug Major Product Offerings
7.4.4 GSK Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Central Nervous System (CNS) Drug Major Product Offerings
7.5.4 Eli Lilly Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Central Nervous System (CNS) Drug Major Product Offerings
7.6.4 Teva Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Otsuka Pharmaceutical Co., Ltd
7.7.1 Otsuka Pharmaceutical Co., Ltd Company Summary
7.7.2 Otsuka Pharmaceutical Co., Ltd Business Overview
7.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Major Product Offerings
7.7.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.7.5 Otsuka Pharmaceutical Co., Ltd Key News & Latest Developments
7.8 Biogen Inc
7.8.1 Biogen Inc Company Summary
7.8.2 Biogen Inc Business Overview
7.8.3 Biogen Inc Central Nervous System (CNS) Drug Major Product Offerings
7.8.4 Biogen Inc Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.8.5 Biogen Inc Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Major Product Offerings
7.9.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Central Nervous System (CNS) Drug Major Product Offerings
7.10.4 Roche Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 UCB
7.11.1 UCB Company Summary
7.11.2 UCB Business Overview
7.11.3 UCB Central Nervous System (CNS) Drug Major Product Offerings
7.11.4 UCB Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.11.5 UCB Key News & Latest Developments
7.12 Tekeda
7.12.1 Tekeda Company Summary
7.12.2 Tekeda Business Overview
7.12.3 Tekeda Central Nervous System (CNS) Drug Major Product Offerings
7.12.4 Tekeda Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.12.5 Tekeda Key News & Latest Developments
7.13 Shanghai Fosun
7.13.1 Shanghai Fosun Company Summary
7.13.2 Shanghai Fosun Business Overview
7.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Major Product Offerings
7.13.4 Shanghai Fosun Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.13.5 Shanghai Fosun Key News & Latest Developments
7.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
7.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Summary
7.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
7.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Major Product Offerings
7.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue in Global Market (2018-2023)
7.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Central Nervous System (CNS) Drug Market Opportunities & Trends in Global Market
Table 2. Central Nervous System (CNS) Drug Market Drivers in Global Market
Table 3. Central Nervous System (CNS) Drug Market Restraints in Global Market
Table 4. Key Players of Central Nervous System (CNS) Drug in Global Market
Table 5. Top Central Nervous System (CNS) Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Central Nervous System (CNS) Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Central Nervous System (CNS) Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Central Nervous System (CNS) Drug Product Type
Table 9. List of Global Tier 1 Central Nervous System (CNS) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Central Nervous System (CNS) Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Central Nervous System (CNS) Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Central Nervous System (CNS) Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Central Nervous System (CNS) Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Central Nervous System (CNS) Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Central Nervous System (CNS) Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2024-2030
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Central Nervous System (CNS) Drug Product Offerings
Table 32. Johnson & Johnson Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Pfizer Inc Company Summary
Table 35. Pfizer Inc Central Nervous System (CNS) Drug Product Offerings
Table 36. Pfizer Inc Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Inc Key News & Latest Developments
Table 38. Novartis AG Company Summary
Table 39. Novartis AG Central Nervous System (CNS) Drug Product Offerings
Table 40. Novartis AG Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis AG Key News & Latest Developments
Table 42. GSK Company Summary
Table 43. GSK Central Nervous System (CNS) Drug Product Offerings
Table 44. GSK Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 45. GSK Key News & Latest Developments
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Central Nervous System (CNS) Drug Product Offerings
Table 48. Eli Lilly Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Central Nervous System (CNS) Drug Product Offerings
Table 52. Teva Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Key News & Latest Developments
Table 54. Otsuka Pharmaceutical Co., Ltd Company Summary
Table 55. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Offerings
Table 56. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Otsuka Pharmaceutical Co., Ltd Key News & Latest Developments
Table 58. Biogen Inc Company Summary
Table 59. Biogen Inc Central Nervous System (CNS) Drug Product Offerings
Table 60. Biogen Inc Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Biogen Inc Key News & Latest Developments
Table 62. Boehringer Ingelheim Company Summary
Table 63. Boehringer Ingelheim Central Nervous System (CNS) Drug Product Offerings
Table 64. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Boehringer Ingelheim Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Central Nervous System (CNS) Drug Product Offerings
Table 68. Roche Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. UCB Company Summary
Table 71. UCB Central Nervous System (CNS) Drug Product Offerings
Table 72. UCB Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 73. UCB Key News & Latest Developments
Table 74. Tekeda Company Summary
Table 75. Tekeda Central Nervous System (CNS) Drug Product Offerings
Table 76. Tekeda Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Tekeda Key News & Latest Developments
Table 78. Shanghai Fosun Company Summary
Table 79. Shanghai Fosun Central Nervous System (CNS) Drug Product Offerings
Table 80. Shanghai Fosun Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Shanghai Fosun Key News & Latest Developments
Table 82. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Summary
Table 83. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Offerings
Table 84. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Jiangsu Nhwa Pharmaceutical Co., Ltd. Key News & Latest Developments
List of Figures
Figure 1. Central Nervous System (CNS) Drug Segment by Type in 2022
Figure 2. Central Nervous System (CNS) Drug Segment by Application in 2022
Figure 3. Global Central Nervous System (CNS) Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Central Nervous System (CNS) Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Central Nervous System (CNS) Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Central Nervous System (CNS) Drug Revenue in 2022
Figure 8. By Type - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 16. US Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 20. Germany Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 28. China Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Central Nervous System (CNS) Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Central Nervous System (CNS) Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Johnson & Johnson Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Inc Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis AG Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GSK Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Biogen Inc Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. UCB Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tekeda Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Shanghai Fosun Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
